Clinical Trial Update: Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on viral kinetics, ISGs, and mirRNA in Chronic Hepatitis C patients treated with sofosbuvir and GS-5816; results posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GS-5816 (GS-5816)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2020-03-19